financetom
Business
financetom
/
Business
/
Market Chatter: BlackRock's Private-Debt Arm Targeting Insurance Firms for Asset Growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: BlackRock's Private-Debt Arm Targeting Insurance Firms for Asset Growth
Jun 12, 2024 8:09 AM

10:32 AM EDT, 06/12/2024 (MT Newswires) -- BlackRock's ( BLK ) private-debt arm is eyeing opportunities to attract investment from insurance firms seeking to expand their exposure to the asset class, to grow its private-debt assets, Bloomberg reported Wednesday, citing the firm's global head of private debt.

The firm currently lacks any formal collaborations, James Keenan reportedly told Bloomberg. It is not yet clear what specific form these partnerships might take, the report said.

BlackRock ( BLK ) did not immediately respond to MT Newswires' request for comment.

Shares of BlackRock ( BLK ) were up more than 3% in early trading.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 780.70, Change: +23.07, Percent Change: +3.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Abeona's Gene Therapy for Rare Eye Disease Selected for FDA Pilot Program
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- Abeona Therapeutics ( ABEO ) said Monday its experimental gene therapy ABO-503 was accepted into the US Food and Drug Administration' Rare Disease Endpoint Advancement Pilot Program, which aims to speed up development of treatments for rare conditions. ABO-503 targets X-linked retinoschisis, a genetic eye disease that affects retinal structure and function. The...
Light & Wonder Provides Update on Nasdaq Delisting Timetable
Light & Wonder Provides Update on Nasdaq Delisting Timetable
Oct 13, 2025
10:36 AM EDT, 10/13/2025 (MT Newswires) -- Light & Wonder ( LNW ) said Monday its Nasdaq delisting will become effective before market open on Nov. 13, as the company transitions to the Australian Securities Exchange as its sole primary listing. The company said its trading on Nasdaq will end on Nov. 12, with suspension after market close, and ASX...
4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study
4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study
Oct 13, 2025
10:34 AM EDT, 10/13/2025 (MT Newswires) -- 4D Molecular Therapeutics ( FDMT ) said Monday that the Cystic Fibrosis Foundation is providing up to $11 million in additional funding to support development of 4D-710 to treat cystic fibrosis lung disease. The company said the first tranche of the funding, worth $7.5 million, closed in October. The second tranche will be...
Market Chatter: Petrobras Restarts Production in Tupi Oil Field Offshore Brazil
Market Chatter: Petrobras Restarts Production in Tupi Oil Field Offshore Brazil
Oct 13, 2025
10:35 AM EDT, 10/13/2025 (MT Newswires) -- Petroleo Brasileiro (PBR), or Petrobras, is resuming production at the Cidade de Angra dos Reis floating production vessel, located in the Tupi oil field offshore Brazil, Bloomberg reported Monday, citing the company's response to emailed questions. The oil giant had completed the work requested by Brazil's oil regulator after the vessel was shut...
Copyright 2023-2026 - www.financetom.com All Rights Reserved